Previous studies have shown that a subset of ERα-positive breast cancers express high levels of mRNA transcripts encoding RET and that RET signaling in ERα-positive breast cancer cell lines can result in the activation of MAPK and AKT, which are important regulators of ERα phosphorylation [43,44]. The gene discussed is RET; the disease is breast carcinoma.